Brasada Capital Management, LP Emergent Bio Solutions Inc. Transaction History

Brasada Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$79.17 - $111.47 $197,925 - $278,675	-2,500 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$81.91 - $134.94 $40,955 - $67,470	500 Added 25.0%	2,500 $258,000
Q2 2020 Jul 14, 2020	BUY	$54.33 - $89.52 $108,660 - $179,040	2,000 New	2,000 $158,000
Q1 2019 May 06, 2019	SELL	$48.23 - $66.16 $289,380 - $396,960	-6,000 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$52.05 - $66.51 $52,050 - $66,510	1,000 Added 20.0%	6,000 $395,000
Q1 2018 May 15, 2018	SELL	$44.44 - $54.39 $266,640 - $326,340	-6,000 Reduced 54.55%	5,000 $6.49 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $415,470 - $525,250	11,000	11,000 $511,000

154

30.2M

137K

706K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $458M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Brasada Capital Management, LP with notifications on news.